|Dr. Howard J. Verrico M.D., Ph.D.||Founder, Chairman, CEO & Sec.||161.28k||N/A||1961|
|Mr. Christopher D. Hopton C.G.A., CPA||CFO & Director||147.84k||N/A||1966|
|Dr. GÃ©raldine Deliencourt-Godefroy Ph.D.||Chief Scientific Officer & Director||213.39k||N/A||N/A|
|Ms. Michelle Seltenrich MBA||VP of Operations||N/A||N/A||N/A|
|Dr. Brett A. Premack Ph.D.||Scientific Consultant||N/A||N/A||N/A|
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. It develops programs in the areas of diabetes, anti-inflammatories, and anti-infectives for therapeutics; and anti-aging and depigmenting agents in cosmeceuticals. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Sirona Biochem Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.